Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.0001 USD
Change Today 0.00 / 0.00%
Volume 0.0
PANC On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 08/25/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Alan W. Dunton M.D.

AgeTotal Calculated CompensationThis person is connected to 31 board members in 4 different organizations across 13 different industries.

See Board Relationships
61--

Background*

Dr. Alan W. Dunton, M.D. has been Consulting Chief Medical Officer of Marina Biotech, Inc. since September 1, 2011. Dr. Dunton founded Danerius, LLC in 2006 and serves as its Principal Owner. Dr. Dunton has been a Senior Consultant of Derma Sciences Inc. since 2012. He serves as a Consultant of Davierius LLC. He served as the Chief Executive Officer of Panacos Pharmaceuticals Inc. from January 8, 2007 to March 2009 and served as President from July 31, 2007 to March ...

Read Full Background

Corporate Headquarters*

134 Coolidge Avenue
Watertown, Massachusetts 02472

United States

Phone: 617-926-1551
Fax: 617-923-2245

Board Members Memberships*

2007-Present
Director
2011-Present
Director, Member of Audit Committee and Member of Compensation Committee
2011-Present
Independent Director, Chairman of Nominating Committee and Member of Audit Committee
2012-Present
Director

Education*

BS
State University of New York
Post-Doctoral Training
NYU Elaine A. and Kenneth G. Langone Medical Center
MD
NYU Elaine A. and Kenneth G. Langone Medical Center

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PANC:US $0.00 USD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ali Mortazavi Chief Executive (leave of absence) and Director
Silence Therapeutics plc
200.0K GBP
Peter French B.Sc, M.Sc, Ph.D., MBAChief Executive Officer, Managing Director and Director
Benitec Biopharma Limited
A$450.0K
Mark W. Schwartz Ph.D.Chief Executive Officer, President, Director and Member of Ad Hoc (Strategy, Pricing, Etc) Committee
Galena Biopharma, Inc.
$707.1K
Paul C. Grint M.D.Chief Executive Officer, President and Director
Regulus Therapeutics Inc.
--
Douglas M. Fambrough III, Ph.D.Co-Founder, Chief Executive Officer, President and Director
Dicerna Pharmaceuticals, Inc.
$430.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PANACOS PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.